Author

India C. Bradley

Washington University in St. Louis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Anastasiia OnyshchenkoiD· 1 shared Ariella L. G. Coler-ReillyiD· 1 shared Damon T. BurrowiD· 1 shared Jan E. CaretteiD· 1 shared Jinmei LiiD· 1 shared Jiwoong ParkiD· 1 shared Malini VaradarajaniD· 1 shared Nicholas C. JacobsiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Anastasiia OnyshchenkoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Sphingolipid Biosynthesis Inhibition As A Host Strategy Against Diverse Pathogens

Sandeep Kumar, Jinmei Li, Jiwoong Park, Sydney K. Hart, Niki Song, Damon T. Burrow, Nicholas L. Bean, Nicholas C. Jacobs, Ariella L. G. Coler-Reilly, Anastasiia Onyshchenko, Tanya Hans Pierre, India C. Bradley, Jan E. Carette, Malini Varadarajan, Thijn R. Brummelkamp, , Timothy R. Peterson

This study identifies that multiple cationic amphipathic drugs (CADs) share molecular similarities with chloroquine and inhibit sphingolipid biosynthesis, suggesting their potential as antiviral agents against diverse pathogens including SARS-CoV-2.

bioRxiv · Apr 10, 2020 · PreprintGenomics